Major players in anatomic pathology track and trace solutions market are Thermo Fisher Scientific (US), Leica Biosystems (Germany), General Data Healthcare (US), Ventana Medical Systems (US), Agilent Technologies (US), Sunquest Information Systems (US), Zebra Technologies (US), Primera Technology (US), Cerebrum Corporation (US), AP Easy Software Solutions (US), and LigoLab (US).
Anatomic pathology track and trace solutions market is projected to reach USD 695.7 million by 2023 from USD 424.2 million in 2018, at a CAGR of 10.4% from 2018 to 2023. Increasing volume of diagnostic tests performed in anatomic pathology laboratories & increasing number of legal cases around cancer misdiagnosis are key factors driving growth of anatomic pathology track and trace solutions market.
Anatomic pathology is the discipline that relies on direct visualization of human tissue, both grossly and microscopically, to render appropriate diagnoses.
Many so-called special stains have been developed, some dating back to the 1800s, for the purpose of identifying and classifying microorganisms in biopsy or excisional specimens.
Report analyzes anatomic pathology track and trace solutions market and aims at estimating size and future growth potential of market and its segments (by product, technology, application, end user, and region). Report also includes a product portfolio matrix of anatomic pathology track and trace solutions available in the market.
Key Target Audience
- Software Providers of Anatomic Pathology Track and Trace Solutions
- Original Equipment Manufacturers
- Hardware System Manufacturers, Suppliers, and Distributors
- Independent and Reference Laboratories
- Histopathology and Cytopathology Laboratories
- Hospital Laboratories
- Reference and Independent Laboratories
- Cancer Treatment Centers
- Contract Research Organizations
- Academic and Research Institutes
- Government Associations
- Market Research and Consulting Firms
- Venture Capitalists and Investors
The anatomic pathology track and trace solutions market is segmented into slide tracking, tissue cassettes and blocks tracking, & specimen tracking. Slide tracking segment is estimated to register highest CAGR during forecast period primarily due to implementation of tracking systems for reducing specimen identification errors & increasing workflow efficiency in anatomic pathology laboratories.
Objectives of the Study
- To define, describe, and forecast the anatomic pathology track and trace solutions market on the basis of product, technology, application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To forecast the size of the anatomic pathology track and trace solutions market with respect to North America, Europe, Asia Pacific, and the Rest of the World
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To profile the key players in the anatomic pathology track and trace solutions market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as R&D activities; product launches; acquisitions; expansions; and collaborations, agreements, and partnerships of the leading players operating in the anatomic pathology track and trace solutions market
In this report, the anatomic pathology track and trace solutions market is segmented based on product, technology, application, end user, and region. Based on product, the market is segmented into software, hardware, and consumables.
In 2018, the software segment is expected to account for the largest share of this market.
Breakdown of Primary Participants from the Demand Side
- By End User: Hospital Laboratories: 45%, Independent and Reference Laboratories: 30%, and Other End Users: 25%
- By Designation: C-level: 43%, D-level: 35%, and Others: 22%
- By Region: North America: 38%, Europe: 26%, Asia Pacific: 24%, and the Rest of the World: 12%